Omalizumab 150mg powder and solvent for solution for injection vials

in short Omalizumab 150mg inj vials

SNOMED code
9742911000001102
Active compound
Omalizumab
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
Caution - AMP level prescribing advised
Non-availability
Actual Products not Available
Non-availability date
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Omalizumab — 150 mg based on ingredient substance
Form & Route
solutioninjection.subcutaneous
Powder and solvent for solution for injection, Subcutaneous
Controlled drug
No Controlled Drug Status

Products

Xolair 150mg powder and solvent for solution for injection vials (Novartis Pharmaceuticals UK Ltd)

in short Xolair 150mg inj vials

Xolair 150mg powder and solvent for solution for injection vials

SNOMED code
9738211000001107
Supplier
Novartis Pharmaceuticals UK Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
Not available
Licensed route
Subcutaneous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Xolair 150mg powder and solvent for solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial
9738311000001104   ref. pack
Discontinued


Legal category: POM
5010678924015
No Price Available
 
previously: £256.15
• Personally Administered
  • • Prescription Charges
  • • Dispensing Fees
  • • Special container
  • • Discount not deducted - automatic

Reference packs

Omalizumab 150mg powder and solvent for solution for injection vials 1 vial
SNOMED code
9738111000001101
Quantity and unit
1 vial
Packs